The effect of adding fenofibrate to phenobarbital in the treatment of prolonged neonatal jaundice
Phase 3
- Conditions
- Prolonged neonatal jaundice.
- Registration Number
- IRCT20201118049433N1
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Infants who are full-term (gestational age between 37 and 41 weeks)
All infants between the ages of 14 and 40 days
All infants weighing between 2500 and 4000 grams
Infants who are breastfed
All infants with total bilirubin 10 to 20 mg/dL
Infants who show no signs of hemolysis on a blood test
Infants who do not have symptoms of an infectious disease or any abnormality
Exclusion Criteria
Infants who are dehydrated
Infants who test positive for Coombs
Infants with indirect bilirubin more than 2 mg/d
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total bilirubin. Timepoint: At the beginning of the study (before the intervention) and 7 days after the start of the procedure. Method of measurement: Bilirubin meter.
- Secondary Outcome Measures
Name Time Method